Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial
Karin Hardt(University of Maryland, Baltimore), Jeffrey J. Stoddard(University of Maryland, Baltimore), Hilde Delanghe(Janssen (Belgium)), Jisha Bhushanan(Janssen (Belgium)), Polan Chetty(Janssen (Belgium)), Brian T. Garibaldi(Johns Hopkins University), Georgi Shukarev(University of Maryland, Baltimore), Hanneke Schuitemaker(University of Maryland, Baltimore), Johan Vingerhoets(University of Maryland, Baltimore), Charles Shey Wiysonge(South African Medical Research Council), Gert C. Scheper(University of Maryland, Baltimore), Pallavi Shetty(Janssen (Belgium)), Victor F. Tapson(Duke Medical Center), D. Lowson(Janssen (United Kingdom)), Jerald Sadoff(University of Maryland, Baltimore), Ilse Scheys(Janssen (Belgium)), Mark R. Looney(University of California, San Francisco), Macaya Douoguih(University of Maryland, Baltimore), Catherine Nalpas(Janssen (Belgium)), Christoph D. Spinner(TUM Klinikum), Frank Struyf(University of Maryland, Baltimore), Tobias Kamphuis(Janssen (Netherlands)), Timothy E. Albertson, Daniel Backenroth(Janssen (Belgium)), Ilse Van Dromme(University of Maryland, Baltimore), An Vandebosch(University of Maryland, Baltimore), José A. Salas(Janssen (Belgium)), Luis Humberto Anaya Velarde(Janssen (Belgium)), Martin Ryser(University of Maryland, Baltimore), Tracy Henrick(Janssen (Belgium)), Saul N. Faust(University Hospital Southampton NHS Foundation Trust), Javier Ruiz‐Guiñazú(University of Maryland, Baltimore), Kimberly L. Cooper(University of California San Diego), Jarek Juraszek(Janssen (Belgium)), Jerome Custers(Janssen (Netherlands)), Carla Truyers(University of Maryland, Baltimore), Sanne Roels(Janssen (Belgium)), A. Duca(Janssen (Belgium)), Bohang Chen(Janssen (Belgium)), Pei-Ling Chu(Royal North Shore Hospital), Fei Chen(Central South University), Janet Lee(Korea Institute of Radiological and Medical Sciences), José Cirı́aco Pinheiro(Janssen (Belgium)), Vicky Cárdenas(University of Maryland, Baltimore), Monika Peeters(Janssen (Belgium)), Johan Van Hoof(University of Maryland, Baltimore), Christian Sandrock, Mathieu Le Gars(University of Maryland, Baltimore), Samantha Santoro Matias(Janssen (Belgium))
Cited by 88
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
|Pediatric Critical Care Medicine|2020|1.2k
Social media and vaccine hesitancy
|BMJ Global Health|2020|962